CADENCE PHARMACEUTICALS INC Business Finance Contracts & Agreements
13 Contracts & Agreements
- Loan Agreements (4 contracts)
- Purchase Agreements (1)
- Share Agreements (2)
- Underwriting Agreements (2)
- Warrant Agreements (4)
- FIRST AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on December 6, 2012)
- WARRANT TO PURCHASE STOCK (Filed With SEC on December 6, 2012)
- SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on December 27, 2011)
- WARRANT TO PURCHASE STOCK (Filed With SEC on December 27, 2011)
- CADENCE PHARMACEUTICALS, INC. (a Delaware corporation) 19,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 16, 2011)
- FIRST AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on November 26, 2010)
- CADENCE PHARMACEUTICALS, INC. (a Delaware corporation) 11,500,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 16, 2010)
- AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on June 21, 2010)
- WARRANT TO PURCHASE STOCK (Filed With SEC on June 21, 2010)
- WARRANT TO PURCHASE SHARES OF COMMON STOCK OF CADENCE PHARMACEUTICALS, INC. (Filed With SEC on February 20, 2009)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 20, 2009)
- Acetavance. We are developing Acetavance in the U.S. market for the treatment of acute pain and fever. According to IMS Health, Inc., or IMS, an independent marketing research... (Filed With SEC on March 13, 2008)
- Acetavance. We are developing Acetavance in the U.S. market for the treatment of acute pain and fever. According to IMS Health, Inc., or IMS, an independent marketing research... (Filed With SEC on March 13, 2008)
